ArticleBMC complementary medicine and therapies2024
Correction: Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach.
Jun Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.